Literature DB >> 28375461

Alzheimer's disease: where next for anti-amyloid therapies?

John Hardy, Bart De Strooper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28375461     DOI： 10.1093/brain/awx059

Source DB:  PubMed          Journal:  Brain        ISSN： 0006-8950            Impact factor:   13.501


× No keyword cloud information.
  19 in total

Review 1.  (-)-Phenserine and Inhibiting Pre-Programmed Cell Death: In Pursuit of a Novel Intervention for Alzheimer's Disease.

Authors:  Robert E Becker; Nigel H Greig; Debomoy K Lahiri; Joseph Bledsoe; Sarah Majercik; Clive Ballard; Dag Aarsland; Lon S Schneider; Douglas Flanagan; Ramprakash Govindarajan; Mary Sano; Luigi Ferrucci; Dimitrios Kapogiannis
Journal:  Curr Alzheimer Res       Date:  2018       Impact factor: 3.498

2.  Editorial Introduction to the Special Issue on Neuropsychological Assessment in Aging.

Authors:  Mathew J Summers; Mark W Bondi
Journal:  Neuropsychol Rev       Date:  2017-11-18       Impact factor: 7.444

3.  Elevated tau PET signal depends on abnormal amyloid levels and is uncommon in unimpaired individuals.

Authors:  Brian A Gordon; Betty M Tijms
Journal:  Brain       Date:  2019-10-01       Impact factor: 13.501

4.  Neurotoxic astrocytes express the d-serine synthesizing enzyme, serine racemase, in Alzheimer's disease.

Authors:  Darrick T Balu; Harry Pantazopoulos; Cathy C Y Huang; Kevin Muszynski; Theresa Lynn Harvey; Yota Uno; Jacki M Rorabaugh; Claire R Galloway; Christian Botz-Zapp; Sabina Berretta; David Weinshenker; Joseph T Coyle
Journal:  Neurobiol Dis       Date:  2019-06-15       Impact factor: 5.996

5.  Interaction of Amyloidogenic Proteins with Membranes and Molecular Mechanism for the Development of Alzheimer's disease.

Authors:  S Banerjee; Y L Lyubchenko
Journal:  Alzheimers Res Ther Open Access       Date:  2019-06-06

6.  Amyloid B-Protein Aggregation at Physiologically Relevant Concentrations. A Critical Role of Membranes.

Authors:  Y L Lyubchenko
Journal:  Alzheimers Res Ther Open Access       Date:  2020-10-28

7.  The mitochondria-targeted antioxidant MitoQ inhibits memory loss, neuropathology, and extends lifespan in aged 3xTg-AD mice.

Authors:  Melissa L Young; James L Franklin
Journal:  Mol Cell Neurosci       Date:  2019-09-12       Impact factor: 4.314

8.  Genetic variants beyond amyloid and tau associated with cognitive decline: A cohort study.

Authors:  Hang-Rai Kim; Taeyeop Lee; Jung Kyoon Choi; Yong Jeong
Journal:  Neurology       Date:  2020-09-16       Impact factor: 9.910

9.  Korean Brain Aging Study for the Early Diagnosis and Prediction of Alzheimer's Disease: Methodology and Baseline Sample Characteristics.

Authors:  Min Soo Byun; Dahyun Yi; Jun Ho Lee; Young Min Choe; Bo Kyung Sohn; Jun-Young Lee; Hyo Jung Choi; Hyewon Baek; Yu Kyeong Kim; Yun-Sang Lee; Chul-Ho Sohn; Inhee Mook-Jung; Murim Choi; Yu Jin Lee; Dong Woo Lee; Seung-Ho Ryu; Shin Gyeom Kim; Jee Wook Kim; Jong Inn Woo; Dong Young Lee
Journal:  Psychiatry Investig       Date:  2017-11-07       Impact factor: 2.505

10.  The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's disease.

Authors:  Craig W Ritchie; Tom C Russ; Sube Banerjee; Bob Barber; Andrew Boaden; Nick C Fox; Clive Holmes; Jeremy D Isaacs; Ira Leroi; Simon Lovestone; Matt Norton; John O'Brien; Jim Pearson; Richard Perry; James Pickett; Adam D Waldman; Wai Lup Wong; Martin N Rossor; Alistair Burns
Journal:  Alzheimers Res Ther       Date:  2017-10-26       Impact factor: 6.982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.